SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period.

ABSTRACT:

SUBMITTER: Boekel L 

PROVIDER: S-EPMC9398211 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature